AbCellera Investor Conference Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 14 PORTFOLIO DIVERSIFIED ACROSS MODALITIES, PARTNER SIZE, AND DEAL TYPE. 69 6 partner-initiated partner-initiated discovery program starts* co-development program starts* 40 partners 8 molecules in the clinic *With downstream participation 12 pre-partnered program starts (TCE, GPCR, ion channel, Covid-19) 2 authorized antibody therapies REGENERON gsk NOVARTIS GILEAD Ablynx A SANOFI COMPANY EMPIRICO Autolus TACHYON Lilly EVEREST MEDICINES SANOFI igences Rallybio angios Lyell teva moderna TM REMAKING MEDICINE Pfizer KODIAK DENALI X Invetx MERCK BILL & MELINDA GATES foundation

View entire presentation